Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
Klaus
B D
BD
Grodesky
M J
MJ
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000378:metabolism / Q000451:nursing*; D019380:Anti-HIV Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy / Q000378:metabolism / Q000451:nursing*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000493:pharmacokinetics / Q000627:therapeutic use; D019888:Nelfinavir / Q000493:pharmacokinetics / Q000627:therapeutic use; D010353:Patient Education as Topic; D011321:Primary Nursing; D019438:Ritonavir / Q000493:pharmacokinetics / Q000627:therapeutic use; D019258:Saquinavir / Q000493:pharmacokinetics / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir